Physician profile

Da Thuy Van

Ophthalmology · Galveston, TX

NPI 1750375580

$710.03

in general payments reported to CMS, 2019-2025

15 companies · none reported in 2025

Payments by year

General and research payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Biotissue Holdings INC. $203.35 2022
Kowa Research Institute, INC. $100.00 2022
Allergan, INC. $74.34 2021-2022
Rxsight INC $73.85 2022
Alcon Vision LLC $69.56 2019-2020
Glaxosmithkline, LLC. $60.41 2022
Sun Pharmaceutical Industries INC. $47.57 2022
Aerie Pharmaceuticals, INC. $41.59 2021
Akorn, INC. $22.12 2019
Bausch & Lomb Americas INC. $17.24 2022

5 companies reported research payments only; those appear in the research section below.

Research and ownership

$59,194.90 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Da Thuy Van

$710.03

in general payments reported 2019-2025

Years
2019-2022
Top company
Bausch Health US, LLC

https://glasscript.com/doctor/261473/da-thuy-van

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.